X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (682) 682
male (409) 409
female (325) 325
middle aged (323) 323
immunoblastic lymphadenopathy - pathology (307) 307
aged (293) 293
immunoblastic lymphadenopathy - diagnosis (258) 258
diagnosis, differential (204) 204
adult (203) 203
lymph nodes - pathology (194) 194
immunoblastic lymphadenopathy - complications (150) 150
index medicus (136) 136
pathology (118) 118
hematology (110) 110
immunoblastic lymphadenopathy - drug therapy (96) 96
immunoblastic lymphadenopathy - immunology (91) 91
lymphoma, t-cell - pathology (90) 90
oncology (89) 89
prognosis (80) 80
angioimmunoblastic t-cell lymphoma (78) 78
lymphadenopathy (72) 72
aged, 80 and over (71) 71
biopsy (69) 69
immunoblastic lymphadenopathy (69) 69
t cells (66) 66
lymphomas (65) 65
lymphoma, t-cell - diagnosis (59) 59
immunohistochemistry (56) 56
non-hodgkin's lymphomas (54) 54
t-cell lymphoma (53) 53
immunoblastic lymphadenopathy - genetics (52) 52
lymphoma (51) 51
angio-immunoblastic lymphadenopathy (49) 49
angioimmunoblastic lymphadenopathy (49) 49
antineoplastic combined chemotherapy protocols - therapeutic use (49) 49
lymphoma, t-cell, peripheral - pathology (48) 48
adolescent (47) 47
diagnosis (44) 44
expression (44) 44
dysproteinemia (43) 43
lymphoma, t-cell - drug therapy (43) 43
epstein-barr-virus (42) 42
lymphoma - diagnosis (42) 42
immunophenotyping (40) 40
lymphoma, t-cell, peripheral - diagnosis (40) 40
medicine, general & internal (40) 40
immunoblastic lymphadenopathy - metabolism (39) 39
lymphoma - pathology (37) 37
lymphoproliferative disorders (37) 37
immunoblastic lymphadenopathy - etiology (36) 36
lymphoma, t-cell - complications (36) 36
treatment outcome (36) 36
child (35) 35
epstein-barr virus (35) 35
immunoblastic lymphadenopathy - therapy (34) 34
non-hodgkins-lymphoma (34) 34
bone marrow - pathology (33) 33
lymphoma, large-cell, immunoblastic - pathology (33) 33
classification (32) 32
features (32) 32
polymerase chain reaction (32) 32
fatal outcome (30) 30
cancer (29) 29
disease (29) 29
t-lymphocytes - pathology (29) 29
chemotherapy (28) 28
immunoblastic lymphadenopathy - mortality (28) 28
lymphoma, t-cell - genetics (28) 28
lymphoma, t-cell - immunology (28) 28
malignant-lymphoma (28) 28
medicine & public health (28) 28
retrospective studies (28) 28
immunoblastic lymphadenopathy - diagnostic imaging (26) 26
herpesvirus 4, human - genetics (25) 25
immunoblastic lymphadenopathy - blood (25) 25
immunoblastic lymphadenopathy - virology (25) 25
plasma cells - pathology (25) 25
prednisone - therapeutic use (25) 25
skin - pathology (25) 25
skin neoplasms - pathology (25) 25
b-lymphocytes - pathology (24) 24
herpesvirus 4, human - isolation & purification (24) 24
hodgkin disease - pathology (24) 24
peripheral t-cell lymphoma (24) 24
tomography, x-ray computed (24) 24
follow-up studies (23) 23
in situ hybridization (22) 22
infection (22) 22
lymphoma, t-cell - metabolism (22) 22
t-lymphocytes - immunology (22) 22
hyperplasia (21) 21
lymphoproliferative disorders - pathology (21) 21
neoplasm staging (21) 21
antineoplastic agents - therapeutic use (20) 20
flow cytometry (20) 20
animals (19) 19
cyclophosphamide - administration & dosage (19) 19
cyclophosphamide - therapeutic use (19) 19
dermatology (19) 19
hypergammaglobulinemia - complications (19) 19
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (557) 557
French (38) 38
Japanese (35) 35
German (21) 21
Chinese (18) 18
Spanish (17) 17
Polish (11) 11
Italian (8) 8
Russian (8) 8
Czech (3) 3
Finnish (3) 3
Dutch (2) 2
Hebrew (2) 2
Hungarian (2) 2
Portuguese (2) 2
Serbian (2) 2
Swedish (2) 2
Croatian (1) 1
Danish (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 02/2010, Volume 115, Issue 5, pp. 1026 - 1036
Journal Article
Medicine, ISSN 0025-7974, 09/2007, Volume 86, Issue 5, pp. 282 - 292
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2010, Volume 65, Issue 4, pp. 855 - 862
Background Angioimmunoblastic T-cell lymphoma (AITL) accounts for 18% of peripheral T-cell lymphomas worldwide. Skin involvement occurs in up to 50% of... 
Dermatology | angioimmunoblastic T-cell lymphoma | peripheral T-cell lymphoma | INVOLVEMENT | LESIONS | DERMATOLOGY | IMMUNOBLASTIC LYMPHADENOPATHY | OVEREXPRESSION | MIMICKING | C-MAF EXPRESSION | NON-HODGKINS-LYMPHOMA | DYSPROTEINEMIA | PD-1 | EPSTEIN-BARR-VIRUS | Arthralgia - pathology | Lymphoma, T-Cell, Cutaneous - virology | Cyclophosphamide - administration & dosage | Prednisolone - administration & dosage | Lymphoma, T-Cell, Cutaneous - diagnosis | Humans | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Lymphoma, T-Cell, Cutaneous - therapy | Male | Vinblastine - administration & dosage | Pruritus - diagnosis | Stem Cell Transplantation | Diphtheria Toxin - therapeutic use | Immunoblastic Lymphadenopathy - diagnosis | Vinblastine - analogs & derivatives | Skin Neoplasms - diagnosis | Vincristine - administration & dosage | Immunoblastic Lymphadenopathy - pathology | Retrospective Studies | Doxorubicin - administration & dosage | Skin Neoplasms - pathology | Skin Neoplasms - therapy | Deoxycytidine - administration & dosage | Gene Rearrangement, T-Lymphocyte | Immunoblastic Lymphadenopathy - virology | Arthralgia - diagnosis | Epstein-Barr Virus Infections - pathology | Lymphoma, T-Cell, Cutaneous - pathology | Immunoblastic Lymphadenopathy - therapy | Skin Neoplasms - virology | Epstein-Barr Virus Infections - diagnosis | Methotrexate - administration & dosage | Aged | Deoxycytidine - analogs & derivatives | Epstein-Barr virus | Non-Hodgkin's lymphomas | Diagnosis | Dendritic cells | T cells | Analysis
Journal Article
American Journal of Hematology, ISSN 0361-8609, 07/2015, Volume 90, Issue 7, pp. 665 - 673
Background: T‐cell lymphomas make up approximately 10%–15% of lymphoid malignancies. The frequency of these lymphomas varies geographically, with the highest... 
POSITRON-EMISSION-TOMOGRAPHY | COMPLETE REMISSION | PROGNOSTIC-FACTORS | NATURAL-KILLER-CELL | NON-HODGKINS-LYMPHOMAS | ANGIOIMMUNOBLASTIC LYMPHADENOPATHY | EUROPEAN GROUP | T/NK LYMPHOMAS | HEMATOLOGY | CLINICOPATHOLOGICAL ENTITY | WORKING PARTY | Leukemia, Large Granular Lymphocytic - diagnostic imaging | Prognosis | Humans | Enteropathy-Associated T-Cell Lymphoma - diagnostic imaging | Lymphoma, Large-Cell, Anaplastic - diagnostic imaging | Male | Risk | Positron-Emission Tomography | Lymphoma, T-Cell, Peripheral - diagnostic imaging | Immunoblastic Lymphadenopathy - diagnosis | Lymphoma, Large-Cell, Anaplastic - diagnosis | Enteropathy-Associated T-Cell Lymphoma - diagnosis | Adult | Female | Immunoblastic Lymphadenopathy - pathology | Leukemia, Large Granular Lymphocytic - pathology | Child | Radiation, Ionizing | Lymphoma, Large-Cell, Anaplastic - therapy | Enteropathy-Associated T-Cell Lymphoma - pathology | Antineoplastic Combined Chemotherapy Protocols | Immunoblastic Lymphadenopathy - diagnostic imaging | Leukemia, Large Granular Lymphocytic - diagnosis | Radiography | Immunoblastic Lymphadenopathy - therapy | Lymphoma, T-Cell, Peripheral - diagnosis | Lymphoma, T-Cell, Peripheral - pathology | Aged | Lymphoma, Large-Cell, Anaplastic - pathology | Lymphoma, T-Cell, Peripheral - therapy | Enteropathy-Associated T-Cell Lymphoma - therapy | Neoplasm Staging | Leukemia, Large Granular Lymphocytic - therapy | T cells | Non-Hodgkin's lymphomas
Journal Article
Journal Article
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 10/2014, Volume 138, Issue 10, pp. 1307 - 1318
Journal Article
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 09/2014, Volume 55, Issue 9, pp. 2038 - 2047
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2017, Volume 176, Issue 6, pp. 851 - 866
Summary Peripheral T‐cell lymphoma (PTCL), not otherwise specified (NOS) and angioimmunoblastic T‐cell lymphoma (AITL) are the most frequent of more than 20... 
treatment | angioimmunoblastic T‐cell lymphoma | pathology | stem cell transplantation | personalized | Peripheral T‐cell lymphoma | angioimmunoblastic T-cell lymphoma | Peripheral T-cell lymphoma | CTLA4-CD28 GENE FUSION | CD30 EXPRESSION | MULTICENTER PHASE-II | OPEN-LABEL | PREVIOUSLY UNTREATED PATIENTS | ALLOGENEIC TRANSPLANTATION | HIGH-DOSE THERAPY | NON-HODGKIN-LYMPHOMA | LONG-TERM REMISSIONS | DETUDE-DES-LYMPHOMES | HEMATOLOGY | Recurrence | Diagnosis, Differential | Prognosis | Standard of Care | Humans | Drug Resistance, Neoplasm | Treatment Outcome | Practice Patterns, Physicians | Combined Modality Therapy - adverse effects | Molecular Targeted Therapy | Drug Discovery | Immunoblastic Lymphadenopathy - therapy | Immunoblastic Lymphadenopathy - diagnosis | Lymphoma, T-Cell, Peripheral - etiology | Lymphoma, T-Cell, Peripheral - diagnosis | Combined Modality Therapy - methods | Disease Management | Lymphoma, T-Cell, Peripheral - therapy | Neoplasm Staging | Transplantation | Non-Hodgkin's lymphomas | T cells | Stem cells | Drugs | Therapy | Gemcitabine | Stem cell transplantation | Lymphocytes T | Drug delivery | Drug development | Doxorubicin | Immunosuppressive agents | Genetic abnormalities | Salvage | Remission | Autografts | Abnormalities | Etoposide | Prednisone | Patients | Vincristine | Lymphoma | Nitric-oxide synthase | Cyclophosphamide | Lymphomas | Health risk assessment | T-cell lymphoma
Journal Article